Agf Investments LLC Agios Pharmaceuticals, Inc. Transaction History

Agf Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$29.58 - $49.78 $415,894 - $699,906	-14,060 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$41.92 - $58.18 $589,395 - $818,010	14,060 New	14,060 $649,000
Q4 2018 Feb 08, 2019	SELL	$42.73 - $76.53 $4,443 - $7,959	-104 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$71.67 - $91.95 $2,436 - $3,126	34 Added 48.57%	104 $8,000
Q3 2018 Nov 07, 2018	SELL	$71.67 - $91.95 $40,493 - $51,951	-565 Reduced 88.98%	70 $27,000

Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $44,957 - $61,123	614 Added 2923.81%	635 $54,000
Q1 2018 May 04, 2018	BUY	$59.83 - $86.53 $1,256 - $1,817	21 New	21 $2,000

207

60M

365K

457K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.31B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.